BioMarin Pharmaceutical Inc. buy Wolfe Research
Start price
15.07.25
/
50%
€49.93
Target price
15.07.26
€81.42
Performance (%)
-2.86%
Price
20:40
€48.50
Summary
This prediction is currently active. With a performance of -2.86%, the BUY prediction for BioMarin Pharmaceutical Inc. by Wolfe_Research is down slightly. This prediction currently runs until 15.07.26. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -5.167% | -5.167% |
| iShares Core DAX® | -0,68 % | -4,85 % |
| iShares Nasdaq 100 | -0,03 % | 2,86 % |
| iShares Nikkei 225® | -0,54 % | -5,02 % |
| iShares S&P 500 | -0,21 % | 0,92 % |
Comments by Wolfe_Research for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was given a new $95.00 price target on by analysts at Wolfe Research. They now have an "outperform" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Wolfe_Research for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€50.46
16.03.26
16.03.26
-
16.03.27
16.03.27
-1.15%
20:40
20:40
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€60.78
15.11.24
15.11.24
€89.95
15.11.25
15.11.25
-22.26%
16.11.25
16.11.25